Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Five patient-first principles to provide the highest standard of healthcare
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
Subscribe To Our Newsletter & Stay Updated
